<p>Two groups each of (<b>A, C</b>) STSA-1 tumor-bearing nude mice (n = 6) and (<b>B, D</b>) DT08/40 tumor bearing mice (n = 6) were either treated with a single dose of 5×10<sup>6</sup> pfu GLV-1h109 or with PBS (mock control) intravenously (i.v.) into lateral tail vein. The statistical significance was confirmed by Student’s t-test where * and ** indicate P<0.05 and 0.01 respectively.</p
<p>Blood samples were collected at day 7, 14, 21 and 28 from (<b>A</b>) STSA-1 and (<b>B</b>) DT08/4...
<p>(A) Treatment of 8-week old female athymic nude mice with IL12-SS1 (Fv) after intraperitoneal inj...
<p>HeLa and HeLa/TSA cells were injected subcutaneously into NOD/SCID mice with four different cell ...
<p>Percentage GFP-positive cells in tumors of STSA-1 xenografted mice 7 days after GLV-1h109- or GLV...
<p>(<b>A</b>) Groups of STSA-1 tumor-bearing nude mice (n = 6) were either treated with a single dos...
<p>(A) Analysis of the effects of GMI (0.3, 0.6, 0.9 and 1.2 μM) on cell viability in A549, A549/D16...
<p>(<b>A</b>) Groups of DT09/06 tumor-bearing nude mice (n = 13) were either treated with a single d...
<p>The mice were either mock-infected or treated with 1×10<sup>7</sup> pfu GLV-1h68 (i.v.) and i.v. ...
<p>Each mouse was <i>s.c.</i> implanted with either 2×10<sup>6</sup> A549 or H1299 cells mixed with ...
<p>Viruses were injected intratumorally 8 days (4T1) and 11 days (CT-26) after engraftment, and a se...
<p>A) Schematic representation of the <i>preventive</i> protocol. Mice were treated daily with eithe...
<p><b>a</b>, Mice bearing BT483-derived breast cancer xenografts with average tumor size of ∼75 mm<s...
<p>(A) Tumor volume, (B) Tumor weight and (C) Body weight. Xenografting was performed by injecting 1...
<p>1×10<sup>7</sup> pfu GLV-1h68 were i.v. injected into PC-3-RFP tumor-bearing mice. (a) PC-3-RFP t...
<p>Mice were treated with 10<sup>7</sup> PFU of Ad5, Ad5T122, or injected with a corresponding volum...
<p>Blood samples were collected at day 7, 14, 21 and 28 from (<b>A</b>) STSA-1 and (<b>B</b>) DT08/4...
<p>(A) Treatment of 8-week old female athymic nude mice with IL12-SS1 (Fv) after intraperitoneal inj...
<p>HeLa and HeLa/TSA cells were injected subcutaneously into NOD/SCID mice with four different cell ...
<p>Percentage GFP-positive cells in tumors of STSA-1 xenografted mice 7 days after GLV-1h109- or GLV...
<p>(<b>A</b>) Groups of STSA-1 tumor-bearing nude mice (n = 6) were either treated with a single dos...
<p>(A) Analysis of the effects of GMI (0.3, 0.6, 0.9 and 1.2 μM) on cell viability in A549, A549/D16...
<p>(<b>A</b>) Groups of DT09/06 tumor-bearing nude mice (n = 13) were either treated with a single d...
<p>The mice were either mock-infected or treated with 1×10<sup>7</sup> pfu GLV-1h68 (i.v.) and i.v. ...
<p>Each mouse was <i>s.c.</i> implanted with either 2×10<sup>6</sup> A549 or H1299 cells mixed with ...
<p>Viruses were injected intratumorally 8 days (4T1) and 11 days (CT-26) after engraftment, and a se...
<p>A) Schematic representation of the <i>preventive</i> protocol. Mice were treated daily with eithe...
<p><b>a</b>, Mice bearing BT483-derived breast cancer xenografts with average tumor size of ∼75 mm<s...
<p>(A) Tumor volume, (B) Tumor weight and (C) Body weight. Xenografting was performed by injecting 1...
<p>1×10<sup>7</sup> pfu GLV-1h68 were i.v. injected into PC-3-RFP tumor-bearing mice. (a) PC-3-RFP t...
<p>Mice were treated with 10<sup>7</sup> PFU of Ad5, Ad5T122, or injected with a corresponding volum...
<p>Blood samples were collected at day 7, 14, 21 and 28 from (<b>A</b>) STSA-1 and (<b>B</b>) DT08/4...
<p>(A) Treatment of 8-week old female athymic nude mice with IL12-SS1 (Fv) after intraperitoneal inj...
<p>HeLa and HeLa/TSA cells were injected subcutaneously into NOD/SCID mice with four different cell ...